DDX3 RNA helicase is required for HIV-1 Tat function

Biochemical and Biophysical Research Communications

Volumn 441, Issue 3, 2013, Pages 607-611

  Yasuda Inoue, Mariko ^a   Kuroki, Misao ^a   Ariumi, Yasuo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

DDX3; HIV 1; P body; Stress granule; Tat

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ARSENIC TRIOXIDE; DEAD BOX PROTEIN; DEAD BOX PROTEIN 1; DEAD BOX PROTEIN 17; DEAD BOX PROTEIN 21; DEAD BOX PROTEIN 3; DEAD BOX PROTEIN 5; DEAD BOX PROTEIN 56; RNA HELICASE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL GRANULE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; STRESS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

DDX3; HIV-1; P-BODY; STRESS GRANULE; TAT;

CELL LINE; CYTOPLASM; DEAD-BOX RNA HELICASES; HIV-1; HUMANS; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84888308330     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.10.107     Document Type: Article

References (29)

1. Jeang K.T., Xiao H., Rich E.A. Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J. Biol. Chem. 1999, 274:28837-28840.
2. Berkhout B., Silverman R.H., Jeang K.T. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 1989, 59:273-282.
3. Hope T.J., Pomerantz R.J. The human immunodeficiency virus type 1 Rev protein: a pivotal protein in the viral life cycle. Curr. Top. Microbiol. Immunol. 1995, 193:91-105.
4. Pollard V.W., Malim M.H. The HIV-1 Rev protein. Annu. Rev. Microbiol. 1998, 52:491-532.
5. Cullen B.R. Nuclear mRNA export: insights from virology. Trends Biochem. Sci. 2003, 28:419-424.
6. Gautier V.W., Gu L., O'Donoghue N., et al. In vitro nuclear interactome of the HIV-1 Tat protein. Retrovirology 2009, 6:47.
7. Ariumi Y., Serhan F., Turelli P., et al. The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription. Retrovirology 2006, 3:47.
8. Rocak S., Linder P. DEAD-box proteins: the driving forces behind RNA metabolism. Nat. Rev. Mol. Cell Biol. 2004, 5:232-241.
9. Cordin O., Banroques J., Tanner K., et al. The DEAD-box protein family of RNA helicases. Gene 2006, 367:17-37.
10. Jankowsky E. RNA helicases at work: binding and rearranging. Trends Biochem. Sci. 2010, 36:19-29.
11. Lorgeoux R.P., Guo F., Liang C. From promoting to inhibiting: diverse roles of helicases in HIV-1 replication. Retrovirology 2012, 9:79.
12. Jeang K.T., Yedavalli V. Role of RNA helicases in HIV-1 replication. Nucleic Acids Res. 2006, 34:4198-4205.
13. Yedavalli V.S., Neuveut C., Chi Y.H., et al. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 2004, 119:381-392.
14. Fang J., Kubota S., Yang B., et al. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev. Virology 2004, 330:471-480.
15. Fang J., Acheampong E., Dave R., et al. The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes. Virology 2005, 336:299-307.
16. Yasuda-Inoue M., Kuroki M., Ariumi Y. Distinct DDX DEAD-box RNA helicases cooperate to modulate the HIV-1 Rev function. Biochem. Biophys. Res. Commun. 2013, 434:803-808.
17. Ariumi Y., Kaida A., Hatanaka M., et al. Functional cross-talk of HIV-1 Tat with p53 through its C-terminal domain. Biochem. Biophys. Res. Commun. 2001, 287:556-561.
18. Ariumi Y., Kuroki M., Abe K., et al. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication. J. Virol. 2007, 81:13922-13926.
19. Ariumi Y., Kuroki M., Kushima Y., et al. Hepatitis C virus hijacks P-body and stress granule components around lipid droplets. J. Virol. 2011, 85:6882-6892.
20. Ariumi Y., Trono D. Ataxia-telangiectasia-mutated (ATM) protein can enhance human immunodeficiency virus type 1 replication by stimulating Rev function. J. Virol. 2006, 80:2445-2452.
21. Brès V., Kiernan R.E., Linares L.K., et al. A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter. Nat. Cell Biol. 2003, 5:754-761.
22. Naldini L., Blömer U., Gallay P., et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996, 272:263-267.
23. Zufferey R., Nagy D., Mandel R.J., et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 1997, 15:871-875.
24. Shih J.W., Wang W.T., Tsai T.Y., et al. Critical role of RNA helicase DDX3 and its interactions with eIF4E/PABP1 in stress granule assembly and stress response. Biochem. J. 2012, 441:119-129.
25. Sharma A., Awasthi S., Harrod C.K., et al. The Werner syndrome helicase is a cofactor for HIV-1 long terminal repeat transactivation and retroviral replication. J. Biol. Chem. 2007, 282:12048-12057.
26. Fujii R., Okamoto M., Aratani S., et al. A role of RNA helicase A in cis-acting transactivation response element-mediated transcriptional regulation of human immunodeficiency virus type 1. J. Biol. Chem. 2001, 276:5445-5451.
27. Cocude C., Truong M.J., Billaut-Mulot O., et al. A novel cellular RNA helicase, RH116, differentially regulates cell growth, programmed cell death and human immunodeficiency virus type 1 replication. J. Gen. Virol. 2003, 84:3215-3225.
28. Soto-Rifo R., Rubilar P.S., Limousin T., et al. DEAD-box protein DDX3 associates with eIF4F to promote translation of selected mRNAs. EMBO J. 2012, 31:3745-3756.
29. Bolinger C., Sharma A., Singh D., et al. RNA helicase A modulates translation of HIV-1 and infectivity of progeny virions. Nucleic Acids Res. 2010, 38:1686-1696.